Innate Pharma S.A. (IPH.PA) Stock Price
€1.76 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
2 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Innate Pharma S.A., AI stock picks, stock alerts and much more.
IPH.PA AI Stock Analysis
AI stock analysis for IPH.PA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Innate Pharma S.A. (IPH.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Innate Pharma S.A. (IPH.PA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Innate Pharma S.A. (IPH.PA), currently trading at €1.76, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About IPH.PA
-
Innate Pharma S.
-
Symbol
IPH.PA
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
147.3M
Similar Stocks
 |
Valneva SE VLA.PA |
€3.15 0.3% |
5 |
 |
Financière de Tubize SA TUB.BR |
€118.4 1.7% |
6 |
 |
OSE Immunotherapeutics SA OSE.PA |
€5.72 1.6% |
6 |
 |
UCB SA UCB.BR |
€149.7 2.6% |
5 |
 |
Pharming Group PHARM.AS |
€0.745 1.2% |
5 |
News
IPH.PA Alternative Data
Web Traffic
Innate Pharma S.A. receives an estimated 8219 monthly visitors to innate-pharma.com.
-
Web Traffic
8219
-
Change from Previous Month
15.9%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Twitter Followers
Innate Pharma S.A. has 4,040 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.
-
Twitter Followers
4040
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
0.6%
Job Postings
Innate Pharma S.A. currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Innate Pharma S.A. has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
News Mentions
Innate Pharma S.A. was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
LinkedIn Followers
27,649 are following Innate Pharma S.A. on LinkedIn, up by 1.1% over the last month.
-
LinkedIn Followers
27649
-
Daily Change
0.1%
-
1 Month Change
1.1%
-
3 Month Change
3.5%
LinkedIn Employees
According to LinkedIn, Innate Pharma S.A. has 197 employees.
-
LinkedIn Employees
197
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
2.1%
IPH.PA Financials
IPH.PA Key Metrics
-
Total Revenue
€6.2M
-
Net Income
-€12.4M
-
Earnings per Share
-€0.15
-
Free cash flow
€1.4M
-
EBITDA
-€12.8M
-
EBITDA Ratio
-2.07072
-
Total Assets
€151.5M
IPH.PA 2-year Revenue & Income
IPH.PA 2-year Free Cash Flow
IPH.PA Technicals
IPH.PA SMA
IPH.PA RSI
FAQ
What's the current price of Innate Pharma S.A. (IPH.PA) Stock?
The price of an Innate Pharma S.A. (IPH.PA) share is €1.76.
What's the market cap of Innate Pharma S.A.?
The current market cap of Innate Pharma S.A. is 147.3M.
Should I buy or sell IPH.PA?
Innate Pharma S.A. shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Innate Pharma S.A. is better viewed as a hold or accumulate position while waiting for further developments.
Is Innate Pharma S.A. a good investment?
The current analysis of Innate Pharma S.A.'s fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Innate Pharma S.A.'s portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Innate Pharma S.A. (IPH.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Innate Pharma S.A. stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Innate Pharma S.A. (IPH.PA) that investors often compare it to?
Innate Pharma S.A. (IPH.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Pharming Group.
What is the forecast for Innate Pharma S.A.'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Innate Pharma S.A.'s stock price to be around €1.72 in 2026. Starting from the current price of €1.76, this represents a 2.4% change in price, indicating a neutral outlook for the stock.
How to buy Innate Pharma S.A. (IPH.PA) Stock?
Innate Pharma S.A. stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Innate Pharma S.A. shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.